International Diabetes Federation. IDF Diabetes Atlas. Ninth Edii. International Diabetes Federation. 2019. 1–141 p.

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.

Avci E, Çakir E, Cevher SC, Yaman H, Agilli M, Bilgi C. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure. Ren Fail. 2014;36(5):767–73.

Article  CAS  PubMed  Google Scholar 

Preciado-Puga MC, Malacara JM, Fajardo-Araujo ME, Wröbel K, Kornhauser-Araujo C, Garay-Sevilla ME. Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study. Exp Clin Endocrinol Diabetes. 2014;122(8):484–90.

Article  CAS  PubMed  Google Scholar 

Lampropoulou IT, Stangou Μ, Sarafidis P, Gouliovaki A, Giamalis P, Tsouchnikas I, Didangelos T, Papagianni Α. TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in type II diabetes mellitus. Clin Immunol. 2020;215: 108423.

Article  CAS  PubMed  Google Scholar 

Lampropoulou IT, Stangou M, Papagianni A, Didangelos T, Iliadis F, Efstratiadis G. TNF- α and microalbuminuria in patients with type 2 diabetes mellitus. J Diabetes Res. 2014;394206. https://doi.org/10.1155/2014/394206.

Barutta F, Bruno G, Grimaldi S, Gruden G. Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. Endocrine. 2015;48(3):730–42.

Article  CAS  PubMed  Google Scholar 

Fathy SA, Mohamed MR, Ali MAM, EL-Helaly AE, Alattar AT. Influence of IL-6, IL-10, IFN-γ and TNF-α genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus patients. Biomarkers. 2019;24(1):43–55.

Gohda T, Nishizaki Y, Murakoshi M, Nojiri S, Yanagisawa N, Shibata T, Yamashita M, Tanaka K, Yamashita Y, Suzuki Y, Kamei N. Clinical predictive biomarkers for normoalbuminuric diabetic kidney disease. Diabetes Res Clin Pract. 2018;141:62–8.

Article  CAS  PubMed  Google Scholar 

Cao L, Boston A, Jegede O, Newman HA, Harrison SH, Newman RH, Ongeri EM. Inflammation and kidney injury in diabetic African American men. J Diabetes Res. 2019;5359635. https://doi.org/10.1155/2019/5359635.

Sangoi MB, de Carvalho JAM, Tatsch E, Hausen BS, Bollick YS, Londero SWK, Duarte T, Scolari R, Duarte MMMF, Premaor MO, Comim FV, Moretto MB, Moresco RN. Urinary inflammatory cytokines as indicators of kidney damage in type 2 diabetic patients. Clin Chim Acta. 2016;460:178–83.

Article  CAS  PubMed  Google Scholar 

Aly RH, Ahmed AE, Hozayen WG, Rabea AM, Ali TM, El Askary A, Ahmed OM. Patterns of toll-like receptor expressions and inflammatory cytokine levels and their implications in the progress of insulin resistance and diabetic nephropathy in type 2 diabetic patients. Front Physiol. 2020;609223. https://doi.org/10.3389/fphys.2020.609223.

Araújo LS, Torquato BGS, Da Silva CA, Dos Reis Monteiro MLG, Dos Santos Martins ALM, Da Silva MV, Dos Reis MA, MacHado JR. Renal expression of cytokines and chemokines in diabetic nephropathy. BMC Nephrol. 2020;21(1):1–11.

Article  Google Scholar 

Hojs R, Ekart R, Bevc S, Hojs N. Markers of inflammation and oxidative stress in the development and progression of renal disease in diabetic patients. Nephron. 2016;133(3):159–62.

Article  CAS  PubMed  Google Scholar 

Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, Sytwu HK, Lin YF. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta. 2010;411(9–10):700–4.

Article  CAS  PubMed  Google Scholar 

Campion CG, Sanchez-Ferras O, Batchu SN. Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy. Can J Kidney Health Dis. 2017;4. https://doi.org/10.1177/2054358117705371.

Lin CH, Chang YC, Chuang LM. Early detection of diabetic kidney disease: present limitations and future perspectives. World J Diabetes. 2016;7(14):290.

Article  PubMed  PubMed Central  Google Scholar 

Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, De Vet HCW, Bossuyt PMM. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):1–17.

Article  Google Scholar 

Chan MW, Leckie A, Xavier F, Uleryk E, Tadros S, Blanchette V, Doria AS. A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children. Haemophilia. 2013;19(6):324–34.

Article  Google Scholar 

Hellemons ME, Kerschbaum J, Bakker SJL, Neuwirt H, Mayer B, Mayer G, de Zeeuw D, LambersHeerspink HJ, Rudnicki M. Validity of biomarkers predicting onset or progression of nephropathy in patients with type2 diabetes: a systematic review. Diabet Med. 2012;29(5):567–77.

Article  CAS  PubMed  Google Scholar 

Kamei N, Yamashita M, Nishizaki Y, Yanagisawa N, Nojiri S, Tanaka K, Yamashita Y, Shibata T, Murakoshi M, Suzuki Y, Gohda T. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes. Sci Rep. 2018;8(1):6–12.

Article  Google Scholar 

Wu J, Ding Y, Zhu C, Shao X, Xie X, Lu K, Wang R. Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes. Exp Ther Med. 2013;6(6):1482–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang D, Ye S, Pan T. The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes. PeerJ. 2019;2019(6):1–14.

Google Scholar 

Kung WJ, Lin CC, Liu SH, Chaung HC. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technol Ther. 2010;12(10):809–13.

Article  CAS  PubMed  Google Scholar 

Li X, Wu TT, Chen J, Qiu W. Elevated expression levels of serum insulin-like growth factor-1, tumor necrosis factor-α and vascular endothelial growth factor 165 might exacerbate type 2 diabetic nephropathy. J Diabetes Investig. 2016;8(1):108–14.

Article  PubMed  PubMed Central  Google Scholar 

Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, Ienaga K, Kondo M. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int. 1991;40(6):1007–12.

Article  CAS  PubMed  Google Scholar 

Navarro JF, Mora C, Macía M, García J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis. 2003;42(1 SUPPL. 2):53–61.

Article  CAS  PubMed  Google Scholar 

Pérez-Morales RE, Del Pino MD, Valdivielso JM, Ortiz A, Mora-Fernández C, Navarro-González JF. Inflammation in diabetic kidney disease. Nephron. 2019;143(1):12–6.

Article  PubMed  Google Scholar 

Sindhughosa DA, Pranamartha AGMK. The involvement of proinflammatory cytokines in diabetic nephropathy: focus on interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α) signaling mechanism. Bali Med J. 2017;6(1):44.

Article  Google Scholar 

Perlman AS, Chevalier JM, Wilkinson P, Liu H, Parker T, Levine DM, Sloan BJ, Gong A, Sherman R, Farrell FX. Serum inflammatory and immune mediators are elevated in early stage diabetic nephropathy. Ann Clin Lab Sci. 2015;45(3):256–63.

CAS  PubMed  Google Scholar 

Emara M, El-Edel R, Fathy WM, Aboelkhair NT, Watany MM, Abou-Elela DH. Study the association of tumor necrosis factor promoter polymorphism with type 2 diabetic nephropathy. Mediators Inflamm. 2020;1498278. https://doi.org/10.1155/2020/1498278

Gupta S, Goyal P, Feinn RS, Mattana J. Role of vitamin d and its analogues in diabetic nephropathy: a meta-analysis. Am J Med Sci. 2019;357(3):223–9.

Article  PubMed  Google Scholar 

Fernández-Real JM, Vendrell J, García I, Ricart W, Valles M. Structural damage in diabetic nephropathy is associated with TNF-α system activity. Acta Diabetol. 2012;49(4):301–5.

Article  PubMed  Google Scholar 

Navarro JF, Mora-Fernández C. The role of TNF-α in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev. 2006;17(6):441–50.

Article  CAS  PubMed  Google Scholar 

Walter MR. Structure of ifnγ and its receptors. Handbook of Cell Signaling, 2/e. 2010;1:261–3.

Law BMP, Wilkinson R, Wang X, Kildey K, Lindner M, Rist MJ, Beagley K, Healy H, Kassianos AJ. Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney Int. 2017;92(1):79–88.

Article  CAS  PubMed  Google Scholar